Differences in genetic instability and cellular phenotype among Barrett's, cardiac, and gastric intestinal metaplasia in a Japanese population with Helicobacter pylori

Histopathology

Volumn 55, Issue 3, 2009, Pages 261-269

  Watari, Jiro ^a,b   Moriichi, Kentaro ^c   Tanabe, Hiroki ^c   Sato, Ryu ^a,c   Fujiya, Mikihiro ^c   Miwa, Hiroto ^b   Das, Kiron M ^d   Kohgo, Yutaka ^c  

^a Kushiro Animal Hospital   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Barrett's oesophagus; Cardiac intestinal metaplasia; Das 1; Gastric intestinal metaplasia; Genetic instability; Helicobacter pylori; Specialized intestinal metaplasia

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DAS 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; DISEASE ASSOCIATION; FEMALE; GASTRIC INTESTINAL METAPLASIA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; JAPANESE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; STOMACH CARDIA INTESTINAL METAPLASIA;

AGED; BARRETT ESOPHAGUS; CARDIA; DNA, NEOPLASM; FEMALE; GASTRIC FUNDUS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOENZYME TECHNIQUES; JAPAN; LOSS OF HETEROZYGOSITY; MALE; METAPLASIA; MICROSATELLITE INSTABILITY; MICROSATELLITE REPEATS; MIDDLE AGED; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

EID: 69549114555     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03370.x     Document Type: Article

References (71)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur. J. Cancer 2001 37 S4 S66.
2. Lauren P. The two histological main type of gastric carcinoma: diffuse and so-called intestinal type carcinoma: an attempt at a histo-clinical classification. Acta Pathol. Microbiol. Scand. 1965 64 31 49.
3. Correa P. Helicobacter pylori and gastric carcinogenesis. Am. J. Surg. Pathol. 1995 19 S37 S43.
4. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988 48 3554 3560.
5. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000 119 333 338.
6. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991 265 1287 1289.
7. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998 83 2049 2053.
8. Hongo M. Review article: Barrett's oesophagus and carcinoma in Japan. Aliment. Pharmacol. Ther. 2004 20 (Suppl. 8 50 54.
9. Prach AT, MacDonald TA, Hopwood DA, Johnston DA. Increasing incidence of Barrett's oesophagus: education, enthusiasm or epidemiology? Lancet 1997 350 933.
10. Ruol A, Parenti A, Zaninotto G et al. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardia. Cancer 2000 88 2520 2528.
11. Sharma P, Weston AP, Morales T, Topalovski M, Mayo MS, Sampliner RE. Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia. Gut 2000 46 9 13.
12. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin. Gastroenterol. Hepatol. 2007 5 1413 1417.
13. Anderson LA, Murphy SJ, Johnston BT et al. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut 2008 57 734 739.
14. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process, First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992 52 6735 6740.
15. Hiyama T, Yokozaki H, Kitadai Y et al. In situ mRNA hybridization technique for analysis of human telomerase RNA in gastric precancerous and cancerous lesion lesions. Jpn. J. Cancer Res. 1998 89 1187 1194.
16. Aldulaimi D, Jankowski J. Barrett's esophagus: an overview of the molecular biology. Dis. Esophagus 1999 12 177 180.
17. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Russell SE. Base transitions at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma. Cancer Res. 1995 55 3406 3411.
18. Tahara E. Molecular mechanism of stomach carcinogenesis. J. Cancer Res. Clin. Oncol. 1993 119 265 272.
19. Loeb LA. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res. 1994 54 5059 5063.
20. Loeb LA, Loeb KR, Anderson JP. Multiple mutations and cancer. Proc. Natl Acad. Sci. USA 2003 100 776 781.
21. Moriichi K, Watari J, Das KM et al. Effects of Helicobacter pylori infection on genetic instability, the aberrant CpG island methylation status and the cellular phenotype in Barrett's esophagus in a Japanese population. Int. J. Cancer 2009 124 1263 1269.
22. Tanaka A, Watari J, Tanabe H et al. Effect of eradication of Helicobacter pylori on genetic instabilities in gastric intestinal metaplasia. Aliment. Pharmacol. Ther. 2006 24 (Suppl. 4 194 202.
23. Zaky AH, Watari J, Tanabe H et al. Clinicopathologic implications of genetic instability in intestinal-type gastric cancer and intestinal metaplasia as a precancerous lesion: proof of field cancerization in the stomach. Am. J. Clin. Pathol. 2008 129 613 621.
24. Das KM, Sakamaki S, Vecchi M, Diamond B. The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: cellular localization of the antigen by using the monoclonal antibody. J. Immunol. 1987 139 77 84.
25. Halstensen TS, Das KM, Brandtzaeg P. Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis. Gut 1993 34 650 657.
26. Das KM, Prasad I, Garla S, Amenta PS. Detection of a shared colon epithelial epitope on Barrett epithelium by a novel monoclonal antibody. Ann. Intern. Med. 1994 120 753 756.
27. Griffel LH, Amenta PS, Das KM. Use of a novel monoclonal antibody in diagnosis of Barrett's esophagus. Dig. Dis. Sci. 2000 45 40 48.
28. Mirza ZK, Das KK, Slate J et al. Gastric intestinal metaplasia as detected by a novel biomarker is highly associated with gastric adenocarcinoma. Gut 2003 52 807 812.
29. Watari J, Das KK, Amenta PS et al. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia. Clin. Gastroenterol. Hepatol. 2008 6 409 419.
30. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N. Engl. J. Med. 1985 313 857 859.
31. Filipe MI, Muñoz N, Matko I et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int. J. Cancer 1994 57 324 329.
32. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum. Pathol. 1994 25 982 993.
33. You WC, Li JY, Blot WJ et al. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int. J. Cancer 1999 83 615 619.
34. Goda K, Tajiri H, Ikegami M, Urashima M, Nakayoshi T, Kaise M. Usefulness of magnifying endoscopy with narrow band imaging for the detection of specialized intestinal metaplasia in columnar-lined esophagus and Barrett's adenocarcinoma. Gastrointest. Endosc. 2007 65 36 46.
35. Glickman JN, Wang H, Das KM et al. Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI. Am. J. Surg. Pathol. 2001 25 87 94.
36. Shibata N, Watari J, Fujiya M, Tanno S, Saitoh Y, Kohgo Y. Cell kinetic and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype. Hum. Pathol. 2003 34 32 40.
37. Boland CR, Thibodeau SN, Hamilton SR et al. A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998 58 5248 5257.
38. Ward R, Meagher A, Tomlinson I et al. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut 2001 48 821 829.
39. Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am. J. Pathol. 1994 145 148 156.
40. Laiho P, Launonen V, Lahermo P et al. Low-level microsatellite instability in most colorectal carcinomas. Cancer Res. 2002 62 1166 1170. (Pubitemid 34160304)
41. Kobayashi K, Okamoto T, Takayama S, Akiyama M, Ohno T, Yamada H. Genetic instability in intestinal metaplasia is a frequent event leading to well differentiated early adenocarcinoma of stomach. Eur. J. Cancer 2000 36 1113 1119.
42. Piazuelo MB, Haque S, Delgado A, Du JX, Rodriguez F, Correa P. Phenotypic differences between esophageal and gastric intestinal metaplasia. Mod. Pathol. 2004 17 62 74.
43. Hackelsberger A, Günther T, Schultze V et al. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut 1998 43 17 21.
44. Ormsby AH, Goldblum JR, Rice TW et al. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum. Pathol. 1999 30 288 294.
45. Ormsby AH, Vaezi MF, Richter JE et al. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus. Gastroenterology 2000 119 683 690.
46. El-Zimaity HM, Graham DY. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens. Am. J. Gastroenterol. 2001 96 1378 1382.
47. Jovanovic I, Tzardi M, Mouzas IA et al. Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction. Histol. Histopathol. 2002 17 445 454.
48. Mohammed IA, Streutker CJ, Riddell RH. Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia. Mod. Pathol. 2002 15 611 616.
49. Mueller J, Werner M, Stolte M. Barrett's esophagus: histopathologic definitions and diagnostic criteria. World J. Surg. 2004 28 148 154.
50. Sarbia M, Donner A, Franke C, Gabbert HE. Distinction between intestinal metaplasia in the cardia and in Barrett's esophagus: the role of histology and immunohistochemistry. Hum. Pathol. 2004 35 371 376.
51. Liu GS, Gong J, Cheng P, Zhang J, Chang Y, Qiang L. Distinction between short-segment Barrett's esophageal and cardiac intestinal metaplasia. World J. Gastroenterol. 2005 11 6360 6365.
52. DeMeester SR, Wickramasinghe KS, Lord RV et al. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus. Am. J. Gastroenterol. 2002 97 2514 2523.
53. Balaji NS, DeMeester SR, Wickramasinghe KS, Hagen JA, Peters JH, DeMeester TR. Etiology of intestinal metaplasia at the gastroesophageal junction. Surg. Endosc. 2003 17 43 48.
54. Goldblum JR, Vicari JJ, Falk GW et al. Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology 1998 114 633 639.
55. Dulai GS, Guha S, Kahn KL, Gornbein J, Weinstein WM. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology 2002 122 26 33.
56. Schnell TG, Sontag SJ, Chejfec G et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001 120 1607 1619.
57. Romagnoli S, Roncalli M, Graziani D et al. Molecular alterations of Barrett's esophagus on microdissected endoscopic biopsies. Lab. Invest. 2001 81 241 247.
58. Meltzer SJ, Yin J, Manin B et al. Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinomas. Cancer Res. 1994 54 3379 3382.
59. Yokozaki H, Yasui W, Tahara E. Genetic and epigenetic changes in stomach cancer. Int. Rev. Cytol. 2001 204 49 95.
60. Sepulveda AR, Santos AC, Yamaoka Y et al. Marked differences in the frequency of microsatellite instability in gastric cancer from different countries. Am. J. Gastroenterol. 1999 94 3034 3038.
61. Csendes A, Smok G, Quiroz J et al. Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia. Am. J. Gastroenterol. 2002 97 554 560.
62. Kang GH, Yoon GS, Lee HK, Kwon YM, Ro JY. Clinicopathologic characteristics of replication error-positive gastric carcinoma. Mod. Pathol. 1999 12 15 20.
63. Halling KC, Harper J, Moskaluk CA et al. Origin of microsatellite instability in gastric cancer. Am. J. Pathol. 1999 155 205 211.
64. Bacani J, Zwingerman R, Di Nicola N et al. Tumor microsatellite instability in early onset gastric cancer. J. Mol. Diagn. 2005 7 465 477.
65. Onuma EK, Amenta PS, Jukkola AF, Mohan V, Borra S, Das KM. A phenotypic change of small intestinal epithelium to that of colonocytes in small intestinal adenomas and adenocarcinomas. Am. J. Gastroenterol. 2001 96 2480 2485.
66. Bowrey DJ, Clark GW, Williams GT. Patterns of gastritis in patients with gastro-oesophageal reflux disease. Gut 1999 45 798 803.
67. Couvelard A, Cauvin JM, Goldfain D et al. Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology. Gut 2001 49 761 766.
68. Craanen ME, Blok P, Dekker W, Ferwerda J, Tytgat GN. Subtype of intestinal metaplasia and Helicobacter pylori. Gut 1992 33 597 600.
69. Genta RM, Gürer IE, Graham DY et al. Adherence of Helicobacter pylori to areas of incomplete intestinal metaplasia in the gastric mucosa. Gastroenterology 1996 111 1206 1211.
70. Rugge M, Correa P, Dixon MF et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment. Pharmacol. Ther. 2002 16 1249 1259.
71. Thomas T, Abrams KR, De Caestecker JS, Robinson RJ. Meta analysis: cancer risk in Barrett's oesophagus. Aliment. Pharmacol. Ther. 2007 26 1465 1477.